Sysmex Corp
(OTC: SSMXY)
|
4:55 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $15.51 | Change: -0.16 | %Change: -1.04% | Volume: 72,418 |
Open: | $ 15.45 | Volume: | 72,418 | |
---|---|---|---|---|
High: | $ 15.53 | Yield(%) | 0.97 | |
Low: | $ 15.44 | P/E Ratio (ttm): | 28.66 | |
Dividend ($): | 0.10 | Market Cap ($): | 9.80B | |
EPS ($) | 0.38 | Shares Out: | 623.50M |
% Price Change (last 4 weeks): | -8.28 |
---|---|
% Price Change (last 13 weeks): | -9.27 |
% Price Change (last 26 weeks): | -14.84 |
% Price Change (last 52 weeks): | -31.01 |
% Price Change (year to date): | -15.44 |
Return on Equity (%): | 11.90 |
---|---|
Return on Assets (%): | 8.50 |
Return on Invested Capital (%): | 11.82 |
Gross Profit Margin (%): | 52.54 |
---|---|
Net Profit Margin (%): | 10.76 |
Operating Profit Margin (%): | 16.75 |
|
|
50-day Moving Average: | $16.57 |
---|---|
200-day Moving Average: | $17.20 |
Avg. Daily Vol. (last 50 days): | 168,606 |
Avg. Daily Vol. (last 200 days): | 99,803 |
52-wk high: | $23.63 |
52-wk low: | $14.79 |
Bid: | $n/a |
Ask: | $n/a |
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. The firm also offers clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. The firm operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
|
Sysmex Corp
1-5-1 Wakinohama-Kaigandori Chuo-Ku Kobe HY 651-0073 Phone: 81.78.265.0500 Fax: n/a http://www.sysmex.co.jp |
Earnings (1year) ($): | 0.38 |
---|---|
Annual Dividend ($): | 0.15 |
Current P/E Ratio (ttm): | 28.66 |
Book Value ($): | 4.58 |
Cash Flow ($): | 0.95 |
Price/Earnings (x): | 28.66 |
---|---|
Price/Sales (x): | 3.39 |
Price/Book (x): | 3.77 |
Price/Cash Flow (x): | 24.46 |
Quick Ratio (x): | 2.24 |
---|---|
Current Ratio (x): | 2.91 |
LT Debt/Equity (x): | 10.80 |
Total Debt/Equity (x): | 12.81 |